Exploring the Role of Thy‐1 and Its Soluble Form Regarding Fibrosis Severity in Primary Biliary Cholangitis and Metabolic Dysfunction‐Associated Fatty Liver Disease

Documenti analoghi

• Impacts of Ramadan Fasting on Metabolic and Hepatic Endpoints in Individuals With Metabolic Dysfunction‐Associated Fatty Liver Disease: A Systematic Review and Meta‐Analysis
  di: A. B. M. Kamrul‐Hasan, et al.
  Pubblicazione: (2025)
• The Efficacy and Safety of Seladelpar for Primary Biliary Cholangitis: A Systematic Review and Meta‐Analysis
  di: Mohamed Abuelazm, et al.
  Pubblicazione: (2025)
• Association of Kidney Stone Disease With Metabolic Dysfunction Associated Liver Disease and Metabolic Dysfunction Associated Steatohepatitis: A National Inpatient Sample Study
  di: Toni Habib, et al.
  Pubblicazione: (2025)
• Effect of Pemafibrate on Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Nationwide Multicenter Study
  di: Yasuyuki Komiyama, et al.
  Pubblicazione: (2025)
• Diagnostic Performance of Fibrosis‐4 Index, Nonalcoholic Fatty Liver Disease Fibrosis Score, AST‐To‐Platelet Ratio Index, and BARD Score Among Young and Older Adults for the Diagnosis of Advanced MASLD Fibrosis: A Retrospective Cohort Study
  di: Frank Lin, et al.
  Pubblicazione: (2025)